| Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
|---|---|---|---|---|---|
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.4209 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.5344 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.5851 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.725 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.822 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.838 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.8845 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 0.9423 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.0577 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.0911 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.1481 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.377 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.4449 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.7098 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | nicotinamide | 1.7109 | VolNormImp Area counts | db/m | ZT5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|